Australia Dna Vaccines Market Size & Outlook, 2020-2028

The dna vaccines market in Australia is expected to reach a projected revenue of US$ 235.1 million by 2028. A compound annual growth rate of 9.5% is expected of Australia dna vaccines market from 2021 to 2028.
Revenue, 2020 (US$M)
$114.1
Forecast, 2028 (US$M)
$235.1
CAGR, 2021 - 2028
9.5%
Report Coverage
Australia

Australia dna vaccines market highlights

  • The Australia dna vaccines market generated a revenue of USD 114.1 million in 2020 and is expected to reach USD 235.1 million by 2028.
  • The Australia market is expected to grow at a CAGR of 9.5% from 2021 to 2028.
  • In terms of segment, recombinant vaccine was the largest revenue generating technology in 2020.
  • Recombinant vaccine is the most lucrative technology segment registering the fastest growth during the forecast period.


Dna vaccines market data book summary

Market revenue in 2020USD 114.1 million
Market revenue in 2028USD 235.1 million
Growth rate9.5% (CAGR from 2020 to 2028)
Largest segmentRecombinant vaccine
Fastest growing segmentRecombinant vaccine
Historical data2017 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationRecombinant vaccine
Key market players worldwideZoetis, Phibro Animal Health Corp Class A, Elanco Animal Health Inc, Merck & Co Inc, KBNP, Choong Ang Vaccine Laboratories (CAVAC), Kyoto Biken Laboratories, Nissenken, Vaxxinova, HIPRA


Other key industry trends

  • In terms of revenue, Australia accounted for 1.9% of the global dna vaccines market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Asia Pacific, Japan dna vaccines market is projected to lead the regional market in terms of revenue in 2028.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 298.9 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

DNA Vaccines Market Companies

Name Profile # Employees HQ Website

Australia dna vaccines market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dna vaccines market will help companies and investors design strategic landscapes.


Recombinant vaccine was the largest segment with a revenue share of 100% in 2020. Horizon Databook has segmented the Australia dna vaccines market based on recombinant vaccine covering the revenue growth of each sub-segment from 2017 to 2028.


Reasons to subscribe to Australia dna vaccines market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia dna vaccines market databook

  • Our clientele includes a mix of dna vaccines market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia dna vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Australia dna vaccines market from 2017 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia dna vaccines market size, by technology, 2017-2028 (US$M)

Australia DNA Vaccines Market Outlook Share, 2020 & 2028 (US$M)

Australia dna vaccines market size, by technology, 2017-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more